intravenous l carnitine L-Carnitine Injection L-Carnitine Injection — 30-Day Supply
Description
L., Thymann T., stergaard M
Neuman, A
Nogo-a antibodies enhance axonal repair and remyelination in neuro-inflammatory and demyelinating pathology
Long-term safety data in humans is limited compared to FDA-approved medications
In addition, PPAR also plays a regulatory role in carnitine synthesis by upregulating the carnitine synthases TMLD, TMABA-DH and BBD
Withdrawal period
